Caspase-3 (CASP3) is a major mediator of apoptosis activated during cellular exposure to cytotoxic drugs, radiotherapy or immunotherapy. It is often used as a marker for efficacy of cancer therapy. However, recent reports indicate that caspase-3 has also non-apoptotic roles such as promotion of tumor relapse and tumor angiogenesis. Therefore, the roles of caspase-3 in tumor progression remain to be defined clearly. In our study, we established caspase-3 knockout (KO) colon cancer cell lines by use of the CRISPR technology. In vitro, caspase-3 knockout HCT116 cells were significantly less clonogenic in soft agar assays. They were also significantly less invasive and more sensitive to radiation and mitomycin C than control cells. In vivo, CASP3KO cells formed tumors at rates similar to control cells but were significantly more sensitive to radiotherapy. They were also less prone to pulmonary metastasis when inoculated either subcutaneously or intravenously. At the mechanistic level, caspase-3 gene knockout appeared to cause reduced EMT phenotypes when compared to parental HCT116 cells. Indeed, they showed significantly increased E-cadherin expression, reduced N-cadherin, Snail, Slug and ZEB1 expression than control cells. Therefore, therapeutic targeting of caspase-3 may not only increase the sensitivity of cancer cell to chemotherapy and radiotherapy, but also inhibit cancer cell invasion and metastasis.
Introduction
Caspases are a 15-member family of cysteine proteases playing essential roles in programed cell death and inflammation. 1 Among them, caspase-3 is a prototypical apoptotic executioner that, upon activation by initiator caspase-8 or caspase-9, cleaves many other functionally critical proteins within the cell, leading to apoptosis. 2 Many anticancer therapies including cytotoxic drugs, radiotherapy or immunotherapy are able to cause tumor cell death by activating caspase-3. As such, caspase-3 activation is used by numerous investigators as a surrogate marker for the efficacy of cancer treatment. However, recent studies painted a more complicated picture of caspase-3 in cancer induction and treatment. One recent study shows that caspase-3, instead of acting as a tumor suppressor, promotes carcinogenesis after cellular exposure to chemicals and radiation. 3 An earlier study
showed that caspase-3 is involved in promoting tumor repopulation after radiotherapy through a paracrine signaling pathway. 4 Another study showed that caspase-3 promotes tumor growth by providing a pro-angiogenic microenvironment. 5 Furthermore, dying bladder cancer cells promote tumor cell repopulation after chemotherapy. 6 In human patients, Flanagan et al. reported that colon cancer patients with low levels of activated caspase-3 had a longer disease-free survival time.
In our study, we established caspase-3 knockout colon cancer cell lines by use of the CRISPR technology and compared their behavior in vitro and in vivo with control cells. Our results showed that caspase-3 not only contributes to drug and radiation resistance but is also involved in regulating colon cancer cell migration, invasion and metastasis.
Materials and Methods

Cell lines
HCT116, HT29 and MDA-MB-231 cells were obtained from the Cell Culture Facility of Duke University School of Medicine. Their identities were verified by microsatellite characterization carried out by personnel at the Cell Culture Facility.
Establishment of caspase-3 knockout or knockdown cell lines
Caspase-3 knockout cell lines were established by use of a lentivirus-based CRISPR/Cas9 system. 13 Target single guided RNA (sgRNA) sequences were identified with an online CRISPR design software at http://crispr.mit.edu. The sgRNA sequence chosen is 5 0 TAGTTAATAAAGGTATCCA 3 0 , which was prepended with a G nucleotide for efficient U6 transcription. Annealed double stranded sgRNA oligos were ligated into the lentiCRISPR v2 vector (a gift from Feng Zhang, Addgene plasmid # 52961) at the BsmBl site, which co-express Cas9 and sgRNA in the same vector. The constructed lentivirus-based CRISPR vectors were prepared, packaged according an established protocol. 13 Subsequently HCT116 cells or MDA-MB-231 cells were infected with sgRNA-encoding lentivirus and cultured in DMEM medium supplemented with 10% FBS. The infected cells were then cultured in DMEN containing 1 lg/ml puromycin for 14 days selection. Surviving cells were plated into 96-well plates with 1 cell per well. Colonies that emerged from single cells were selected and expanded for western blot analysis. Those clones without caspase-3 protein expression were selected for further analysis. The primers used to amplify caspase-3 gene sequences surrounding the target gene site were 5 0 GCAAAGAAATCATTATCCCCAG 3 0 (Forward) and 5 0 TTTGCTTATTACACATCCCCAT 3 0 (Reverse). PCR products were purified and then subjected Sanger sequencing to verify gene disruption.
Caspase-3 knockdown HT29 cell lines were established by use of shRNA-encoding lentivirus vectors purchased from Open Biosystems (now Thermo-Fisher, Waltham, MA): Clone 1: V2LHS_15044; Clone 2:V2LHS_15045. HT29 cells were infected with shRNA-encoding lentivirus and then cultured in DMEN containing 1 lg/ml puromycin for 14 days selection.
Western blot
Cells were washed with PBS, and then lysed in RIPA buffer supplemented with protease inhibitors. Equal amounts of proteins were separated by SDS-PAGE and transferred to a PVDF membrane. Proteins were probed with specific antibodies followed by secondary antibodies conjugated with HRP. The HRP signal was developed by using ECL.
Growth curve
Cells were seeded into 96-well plates at increasing densities from 200 cells/well to 6,400 cells/well. Growth curve for cells measured using the MTT assay. Briefly, cells were stained daily by use of the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) reagent (ATCC). Cellular densities were then measured at 570 nm by use of a Biotek Synergy H1 plate reader. Five wells were plated for each seeding density of each cell type.
ELISA assay for prostaglandin E 2 (PGE 2 ) concentration HCT116 caspase-3 KO or vector control cells were treated or untreated with X-ray radiation at 10 Gy and plated in sixwell plates (1 3 10 6 cells/well) in 2% fetal bovine serum culture medium. Supernatant from the cells was collected 96 hr after radiation and diluted eightfold. Cells were counted by using the Bio-Rad (Hercules, CA) cell counter to normalize PGE 2 concentration to cell number. The concentration of PGE 2 in the supernatant was measured following a protocol from an ELISA kit purchased from Cayman Chemical Company (Ann Arbor, MI).
Clonogenic survival assay
To measure cellular sensitivity to cytotoxic therapy such radiation and chemical treatments, clonogenic survival assay was performed. Briefly, the cells were treated with mitomycin C at different concentration for 72 hr or irradiated with different doses of X-rays. They were then plated in triplicate 10-cm dishes at different numbers according to mitomycin C concentration or radiation doses so that there would be 50- 
Soft agar colony formation assay
To measure the ability of cells to growth in 3D, soft agar assay was performed according to an established protocol.
14 Cells were seeded at a density of 500 cells per well in six-well plates in triplicate. After growth in the plates for 21 days, the colonies were fixed and stained with 0.005% crystal violet. Images of each well were taken and the number of colonies per well were counted.
Radiation exposure
Cells or mice were irradiated by use of a Precision X-RAD 320 (Precision X-Ray, Inc., North Branford, CT) machine operating at 320 kVp and 12.5 mA. During irradiation, a lead shield protected the mice's vital organs while the hind limb is the only part of the mouse that was exposed.
Transwell migration and invasion assay
For transwell migration and invasion assay, 5 3 10 4 and 1 3 10 5 cells were suspended, respectively in 200-ml serum-free medium for 30 min, and then added to the upper chambers (Falcon TM Cell Culture Inserts, Corning, Inc., Tewksbury, MA). Medium containing 10% FBS was added to the lower chambers (24-well plates, Corning, Inc., Tewksbury, MA). After incubation for 24 hr (HCT116) or 40 hr (HT29) at 378C in a humidified atmosphere with 5% CO 2 , cells were then fixed with 4% paraformaldehyde in PBS and stained with 1% crystal violet. The upper surfaces of the filters were scraped five times with cotton swabs to remove non-migrated cells. The experiments were repeated in triplicate wells, and the migrated cells were counted microscopically in five randomly selected fields per filter under the microscope.
Scratch assay
Scratch assay was performed with slight modifications according to previous protocol. 15 In brief, cells were seeding into six-well plates at 2 3 10 6 cells/well. Incubate the plates at 378C for 6 hr to allowing cells to adhere and spread completely. Use a P200 pipette tip to create a straight line in the cell monolayer. Wash the plates three times with PBS and replace with serum-free medium. Observe the cells under a microscope and take pictures for further analysis. For each image, distances between one side of scratch and the other were measured.
Cell adhesion assay
CytoSelect TM 48-well cell adhesion assay (ECM Array, Colorimetric Format, Cell Biolabs, Inc., San Diego, CA) was performed according to manufacturer's instructions. In brief, 5 3 10 4 cells were suspended in serum-free medium, added into the wells (pre-coated with adhesive substrates) and then incubated at 378C for 90 min in a cell culture incubator. After five times wash with PBS, adherent cells were stained and quantified at OD560 by using a microtiter plate reader (BioTek, Winooski, VT).
In vivo tumor invasion and metastasis analysis
Luciferase-labeled caspase-3 knockout cells and controls cells were generated by infecting the cells with a lentivirus carrying a firefly luciferase gene. The luciferase signal of cultured cells was imaged by adding PBS with D-luciferin (Caliper Life Sciences, Hopkinton, MA) at a concentration of 0.15 mg/ml. Single cell colonies exhibited similar luciferase signal were selected and expanded for later use. About 5 3 10 6 /mice were injected to the tail veins of 6-week-old female nude mice (4 mice per group) for in vivo tumor invasion and metastasis analysis. Prior to imaging, mice were injected with 150 mg/kg of D-luciferin intraperitoneally in 200 ll of PBS and then anesthetized with continuous flow of isoflurane. Imaging of the mice was carried out 10 min later by use of the IVIS200 instrument (Caliper Life Sciences, Hopkinton, MA). Mice were imaged on Days 0, 12, 20 and 32. Images were taken and analyzed by use of manufacturer supplied software for quantitative data. The body weight change of each mouse was measured every other day. Once any one of the mice's body weight decreased by 15%, all mice in the group were sacrificed and lung weights of each mouse were recorded.
In vivo tumor growth delay
Tumor cells (1 3 10 6 cells in 50 ll PBS) were injected into the hind limb of the nude mice subcutaneously. The mice were then monitored for tumor growth every other day. Tumor sizes were measured by use of a caliper. When tumors reach 5-7 mm in diameter, some of them were exposed to x-irradiation (2 3 8 Gy 1 day apart).
Immunofluorescence analysis
Cells grown in glass bottom dishes were fixed in 4% paraformaldehyde solution for 20 min. After three washes with PBS, cells were permeabilized and blocked with a PBS solution containing 1% Triton X-100, 5% donkey serum and 1% BSA for 1 hr. Thereafter, cells were incubated with primary antibody overnight at 48C, followed by incubation with Alexa Fluor 488-conjugated secondary antibody for 1 hr at RT. After three washes with PBS, the stained cells were mounted with mounting medium (Vector Laboratories, Burlingame, CA) containing DAPI. Images were captured by use of confocal microscopy.
Antibodies
The caspase-3 (full length, clone 8G10) antibody and EMT antibody sampler Kit #9782 were purchased from Cell Signaling Technology (Danvers, MA).
Statistical analysis
Data were presented as mean 6 SEM. One-way ANOVA was performed for multiple group comparisons and comparisons between two groups were conducted using the LSD method (plating efficiencies, soft agar assay, growth curve, clonogenic survival assay, transwell migration and invasion assay). Statistical significance was also determined by paired t-tests (in vivo tumor invasion and metastasis analysis, scratch assay) and log-rank tests (survival curve). A p-values <0.05 was considered statistically significant.
Results
Reduced in vitro tumorigenic abilities of HCT116-CASP3KO colon cancer cells
To investigate the biological roles of caspase-3 in colon cancer cells, we attempted to establish CASP3 knockout HCT116 cells by use of the lentivirus-based CRISPR/Cas9 technology.
13 HCT116 cells were infected with a lentivirus encoding Cas9 and sgRNAs targeting the caspase-3 gene. Individual clonal populations were then screened by Western blot analysis for caspase-3 expression. Two independent clones without caspase-3 expression were obtained (Fig. 1a) . Sequencing results showed that the start codon ATG was deleted in both of the clones (Supporting Information Fig. S1 ). When we examined the effects of caspase-3 gene deficiencies on the tumorigenic abilities of the HCT116 cells in vitro by use of the soft agar assay, which measures the anchorage independent growth abilities of cells unique to cancer cells, our results indicated that CASP3 knockout cells had significantly reduced soft agar colony forming abilities (Figs. 1b and 1c ) when compared to vector control cells. There were only <20 colonies per well on average in caspase-3 knockout cells (out of 500 cells plated) while >100 colonies/per well were observed in vector control cells. To determine if the growth properties were influenced by cellular density, we evaluated the cellular growth at different initiating cellular densities. When cells were seeded at high densities, the growth rates of CASP3 knockout cells and control cells were almost equal (Fig. 1d) . However, CASP3 knockout cells grew more slowly than control cells when cells were plated at low densities (Fig. 1d) . These results therefore showed that Caspase-3 plays important roles in promoting the tumorigenic abilities of colon cancer cells in vitro, especially at lower densities. It is interesting to note that soft agar colonies were also plated at very low cell densities. However, the difference observed in 3D soft agar colony assay (Figs. 1b and 1c) were much bigger than those observed for growth in 2D, suggesting that additional biological properties such as invasion and the ability to cut through extracellular matrix is also affected in CASP3KO cells. We also did experiments to determine if CASP3 deficiency caused any changes cellular abilities to adhere to matrix or Petri dish surface. Our results (Supporting Information Fig. S2 ) indicate no such differences exist. Furthermore, there was no difference in apoptosis rate between CASP3KO cells and vector control cells (Supporting Information Fig. S3 ).
Increased sensitivities to radiotherapy and chemotherapy in CASP3 knockout cells
Chemotherapy and radiotherapy are commonly used to treat patients with colon cancer. To understand the function of caspase-3 during chemotherapy and radiotherapy, we first exposed CASP3KO HCT116 cells to anticancer drug mitomycin C at different concentrations. We then determined the clonogenic survival of the cells in Petri dish. Our results showed caspase-3 knockout cells were more sensitive to mitomycin C, especially when the concentration of mitomycin C was high (Fig. 2a) . A similar phenotype was observed in colony forming assays conducted for cells exposed to X-rays. Besides the lower clonogenicity (number of colonies formed from 100 seeded cells) of CASP3KO cells when compared to the vector control cells (Supporting Information Fig. S4 ), CASP3KO cells were significantly more sensitive to radiation than vector control cells only at high radiation doses (Fig.  2b) . To verify these results in other cell lines, we established CASP3 knockdown HT29 cell line and a CASP3KO MDA-MB-231 cell line (Supporting Information Figs. S5a and S5b). Consistent with results obtained in HCT116CASP3KO cells, enhanced radiation sensitivities could be observed in the CASP3KO MDA-MB-231 cells (Supporting Information Fig.  S5c ). Furthermore, CASP3 knockdown HT29 cells were more sensitive to mitomycin C and X-ray radiation (Figs. 2c and  2d) . In a subsequent experiment, we treated the HCT116 cells with Caspase-3 inhibitor Z-DEVD-FMK and then exposed to different concentrations of mitomycin C or different doses of X-rays. The results of clonogenic assay, as shown in Supporting Information Figure S6 , indicated that caspase-3 inhibitor could sensitize the cells to mitomycin C and X-ray radiation. These results were very similar to those observed for CASP3KO HCT116 cells.
We next evaluated the growth rates of control and CASP3KO cells in vivo. Subcutaneously injected vector control and CASP3KO HCT116 cells formed tumor in nude mice at almost equal rates under non-treated condition (Fig.  2e) . However, radiotherapy caused significantly more growth delay in CASP3KO HCT116 tumors (Fig. 2e) . These results indicate that caspase-3 gene plays a significant role in tumor response to radiotherapy. It is worth noting that CASP3KO caused significant attenuation in soft agar colony growth but makes no difference in in vivo tumor growth in the absence of radiotherapy (Figs. 1b and 1c vs. Fig. 2e ). The underlying reason is not entirely clear. We reason that it might be caused by the effects of cellular densities, similar to those observed for growth assay (Fig. 1d) . Our previous data 4, 16 showed that caspase-3 could mediate the production of prostaglandin E 2 (PGE 2 ), a growth regulator that increases tumor growth in many types of cancers, including colon cancer. [17] [18] [19] To determine if CASP3KO caused difference in PGE 2 production, we measured PGE 2 levels in supernatants from control and irradiated HCT116 cells. Our results indicate the significantly reduced level of PGE 2 was found in HCT116 CASP3KO cells when compared to the control cells under both non-irradiated and irradiated conditions (Supporting Information Fig. S7 ). Therefore, it is quite possible that the reduced level of PGE 2 and other growth factors in CASP3KO cells is compensated at higher cellular densities in mice, where 1 million cells were injected per mouse. Another interesting observation from the experiments is that radiotherapy enabled mice bearing CASP3KO tumors to survive (Lack of survival was defined as death of host or tumor volume 2,000 mm 3 ) significantly longer than those bearing control tumors (Fig 2f) . Furthermore, two of the five mice bearing CASP3KO tumors treated with radiotherapy survive beyond 100 days while none of the mice bearing control tumors did (Fig. 2f) .
Reduced invasiveness and metastatic potential of CASP3KO cells
To investigate the role of caspase-3 in regulating cancer cell migration and invasion, we conducted migration and invasion assays by use of transwell plates. Our results showed that HCT116 CASP3KO or HT29 CASP3 knockdown cells possessed significantly less migration and invasion capacities (Figs. 3a and 3b and Supporting Information Figs. S8a and S8b). In addition, HCT116 CASP3KO they also showed significantly reduced migration ability in scratch assays (Supporting Information Figs. S9a and S9b). To validate our in vitro results, we established luciferase-labeled CASP3KO and control cells. In vitro, the two cell lines have almost identical luciferase activities (Supporting Information Fig.  S10 ). In addition, their luciferase activities showed a linear relationship with cell numbers (Supporting Information Fig.  S10 ). The labeled cells were then intravenously injected into nude mice and observed for their abilities to establish metastasis by use of an in vivo optical imaging system. Our results showed that despite very similar luciferase activities right after tumor cell injection (Day 0), the abilities of CASP3KO cells to establish lung metastases were significantly reduced compared to control cells (Figs. 3c and 3d) . In fact, we could not detect any luciferase signals in mice injected with CASP3KO cells 32 days after the tail vein injection while in mice injected with control cells, luciferase activities showed a steady increase from Day 12 to Day 32 (Figs. 3c and 3d) . Upon mouse sacrifice and examination at 32 days post inoculation, lungs of control group mice were full of metastatic nodules while those of CASP3KO mice had no nodules at all (Fig. 3e) . Lung weights of control group mice were 50% higher than that of CASP3KO group mice (Fig. 3f) . Independently, reduced invasiveness and metastatic potential of CASP3KO cells were also observed in mice with subcutaneously established local tumors (mice from Figs. 2e and 2f). After radiotherapy, none (0 of 5) of the irradiated CASP3KO tumor-bearing mice developed pulmonary metastasis while 60% (3 of 5) of irradiated control tumor-bearing mice developed pulmonary metastasis when the lungs of the mice were visually examined upon their sacrifice (when they become morbid or when their tumors reach 2,000 mm 3 or bigger, whichever comes first). Furthermore, lung metastasis in the control tumor-bearing mice was confirmed by H&E staining (Fig. 3g) . These results support a significant role for caspase-3 in mediating the metastatic abilities of colon cancer cells in vivo. Roles of caspase-3 in mediating epithelial-to-mesenchymal transition (EMT) in colon cancer cells
What are the mechanisms involved in CASP3-mediated cancer cell migration and invasion? Under the microscope, HCT116-CASP3KO cells exhibited altered cellular morphology with decreased lamellipodia and substantial reduction in cellular spreading when compared to the control cells (Fig.   4a ). The morphology observations were further confirmed with phalloidin staining of F-actin (Fig. 4b) .
The observed morphology changes in HCT116 CASP3KO cells provided clues that Caspase-3 may contribute to epithelial to mesenchymal transition (EMT). To determine if this is true, we examined the EMT marker expression in control and CAPS3KO cells. Western blot results verified our speculation. Compared to control cells, epithelial marker Ecadherin was expressed at higher levels in CASP3KO cells (Fig.  4c) . In comparison, mesenchymal marker N-cadherin, snail, slug and ZEB1 were expressed at significantly reduced levels in CASP3KO cells (Fig. 4c) . Immunofluorescence assay further demonstrated CASP3 knockout cells with higher levels of E-cadherin expression (Supporting Information Fig. S11 ). Furthermore, compared to the control cells, a reduction of beta-catenin expression in the nuclei and an increase in the membrane protein location were detected by immunofluorescence (Fig. 4d) . Activation and nuclear migration of b-catenin has been reported to be another indication of EMT transition. 20, 21 Independently, upregulated epithelial marker (E-cadherin) and downregulated mesenchymal markers (N-cadherin, snail, slug and ZEB1) were also detected in CASP3 shRNA HT29 cells when compared to the scramble control (Supporting Information Fig. S12 ). Taking together, our results therefore suggest a role for caspase-3 in mediating an EMT phenotype in HCT116 and HT29 colon cancer cells.
Discussion
Increased caspase-3 activities are generally considered as a sign of apoptosis and a positive indicator of efficacy in cancer treatment. Recently, there is increasing evidence that caspase-3 promotes stress-induced cancer cell growth, cellular migration, invasiveness and tumor angiogenesis. 5, [22] [23] [24] In human cancer treatment, several studies reported that patients with higher levels procaspase-3 or active caspase-3 had worse prognosis than patients with lower levels of procaspase-3 or active caspase-3. 7, [25] [26] [27] In our study, we explored the function of caspase-3 in colon cancer cells by comparing CASP3 knockout cells with vector control cells.
Our results from our study are consistent with the growing body of literature that supporting the non-apoptotic roles of "apoptotic" caspases in mammalian biology. Indeed, in cancer biology, apoptosis may not be a dominant way of cell death even after cytotoxic therapy. 28 This is in contrast to leukemia or lymphoma cells, where apoptosis plays a prominent role in tumor cell response to treatment. However, the lack of cell death through apoptosis in solid tumors does not mean that apoptotic caspases play no role in solid tumor biology. In contrast, caspases appear to play a significant number of non-canonical roles in solid tumor biology.
Although CASP3 knockout cells are less tumorigenic in soft agar assays when compared to the control cells, their growth rates in vitro in 2D and in vivo are not affected when cells seeded or injected at high densities. Impaired growth of CASP3 knockout cells only found when cells seeded in low densities. Those observations are consistent with reduced PGE 2 production in CASP3KO cells, which either alone or in combination with other growth factors may be responsible for the observed discrepancies between high and low density knockout cells. Furthermore, CASP3 knockout cells are more sensitive to mitomycin C and radiation than vector control cells, results that go against the conventional wisdom that activation of caspase-3 is good for killing cancer cells. Those in vitro results were further confirmed by in vivo experiments where CASP3KO cell-derived tumors showed increased growth delay to radiotherapy. The most striking results were perhaps those demonstrating caspase-3 ablation completely abolished the abilities of HCT116 cells to metastasize to the lung, thereby demonstrating an important role for caspase-3 in colon cancer that has not been revealed before.
Our findings on the role of caspase-3 in metastasis of HCT116 colon cancer cells are important because metastasis accounts for the majority of failures in colon cancer treatment. At the mechanistic level, we showed that caspase-3 is involved in regulating EMT. EMT plays a major role in basal membrane degradation, cell migration and survival of invasion cells in a new environment. 29 When the cells undergo EMT, they may change the morphology, lose their cell-cell junctions while retaining expression of migration-promoting molecules. 29 Our experiments clearly show that CASP3KO cells lost key EMT features that were prominent in parental HCT116 cells. These findings provide a rational explanation on why the loss of caspase-3 causes HCT116 colon cancer cells to lose their abilities to metastasize. Since caspase-3 promotes colon cancer resistance to radiotherapy and chemotherapy as well as colon cancer cells invasion and metastasis, combining chemotherapy or radiotherapy with caspase-3 targeted agents may thus be a promising approach for colon cancer treatment.
